Latest News & Updates
Exclusive Access for In-House Counsel
Qualified applicants may attend at no cost—apply now to reserve your place.
The Premier Forum for Paragraph IV and Hatch-Waxman Litigation
Join American Conference Institute’s 23rd Annual Paragraph IV Disputes Conference, the nation’s leading forum for pharmaceutical patent litigation, returning to New York. This must-attend event brings together brand and generic pharmaceutical companies, in-house counsel, private practice attorneys, members of the judiciary, and government representatives to explore the latest developments shaping Hatch-Waxman litigation.
Stay ahead of emerging legal, regulatory, and business challenges while gaining practical strategies from the industry’s leading voices.
Join your peers to:
- Benchmark strategies with leading ANDA litigators, in-house counsel, and regulators
- Examine the latest case law, PTAB developments, and litigation trends
- Build valuable connections with the leaders shaping pharmaceutical patent litigation
ACI’s Hatch-Waxman Series Advisory Board
Comprised of senior in-house IP counsel from top brand and generic pharma companies, the Advisory Board guides ACI on key litigation trends and emerging issues to ensure leading-edge content and expert faculty.
View Advisory Board
3,700+
Attendees
560+
Speakers
110+
Sponsors
Who Should Attend
Patent attorneys and litigators (in-house & law firms) who represent:
- Brand name pharmaceutical companies
- Generic pharmaceutical companies
- Biopharmaceutical companies
Earn CLE/Ethics Credits
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.
Learn moreSponsors & Partners
Media Partner
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]
